Anaerobic Infections
- 1 May 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 70 (7), 841-858
- https://doi.org/10.2165/11534490-000000000-00000
Abstract
Anaerobic bacteria are the predominant indigenous flora of humans and, as a result, play an important role in infections, some of which are serious with a high mortality rate. These opportunistic pathogens are frequently missed in cultures of clinical samples because of shortcomings in collection and transport procedures as well as lack of isolation and susceptibility testing of anaerobes in many clinical microbiology laboratories. Correlation of clinical failures with known antibacterial resistance of anaerobic bacteria is seldom possible. Changes in resistance over time, and the discovery and characterization of resistance determinants in anaerobic bacteria, has increased recognition of problems in empirical treatment and has even resulted in changes in treatment guidelines. This review discusses the role of anaerobic bacteria in the normal flora of humans, their involvement in different mixed infections, developments in antibacterial resistance of the most frequent anaerobic pathogens and possible new treatment options.Keywords
This publication has 114 references indexed in Scilit:
- In Vitro Activities of Telavancin and Six Comparator Agents against Anaerobic Bacterial IsolatesAntimicrobial Agents and Chemotherapy, 2009
- A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responsesNature Medicine, 2009
- Gene Context and DNA Rearrangements in the Carbapenemase Locus of Division II Strains of Bacteroides fragilisAntimicrobial Agents and Chemotherapy, 2009
- Antianaerobic Activity of Sulopenem Compared to Six Other AgentsAntimicrobial Agents and Chemotherapy, 2009
- In Vitro Activity of Tomopenem (CS-023/RO4908463) against Anaerobic BacteriaAntimicrobial Agents and Chemotherapy, 2009
- Association of EnterotoxigenicBacteroides fragilisInfection with Inflammatory DiarrheaClinical Infectious Diseases, 2008
- Increasing Trends in Antimicrobial Resistance among Clinically Important Anaerobes and Bacteroides fragilis Isolates Causing Nosocomial Infections: Emerging Resistance to CarbapenemsAntimicrobial Agents and Chemotherapy, 2008
- Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficileAntimicrobial Agents and Chemotherapy, 2008
- Resistance Trends of the Bacteroides fragilis Group over a 10-Year Period, 1997 to 2006, in Madrid, SpainAntimicrobial Agents and Chemotherapy, 2008
- Comparative In Vitro Susceptibilities of 396 Unusual Anaerobic Strains to Tigecycline and Eight Other Antimicrobial AgentsAntimicrobial Agents and Chemotherapy, 2006